Obagi Medical Products files with SEC for $100 million stock offering
Obagi Medical Products, Inc. (Nasdaq: OMPI) reported this morning that it filed with the Securities and Exchange Commission for a proposed offering of up to $100 million of its common stock.
The specialty pharmaceutical company said a majority of the shares sold in the offering will be sold by selling stockholders and the remainder of the shares sold will be done so by Obagi.
Shares of Obagi were halted in pre-market trading.
